Iterative Health is pioneering the use of artificial intelligence-based precision medicine in gastroenterology (GI), with the aim of helping to optimize clinical trials investigating treatment of inflammatory bowel disease (IBD). We use advanced machine learning and computer vision to interpret endoscopic images along with other types of data, helping clinicians to better assess patients with potential GI problems. This gives practitioners enhanced capabilities in the detection, annotation, disease scoring and treatment of GI related diseases. Iterative Health is initially applying these advances towards standardizing disease severity characterization for inflammatory bowel disease. Ultimately, the company aims to establish more meaningful endpoints to serve as better predictors of both therapeutic response and disease outcomes. The company is headquartered in Cambridge, Massachusetts. Recruitment Impersonation Notice: It has come to our attention that one or more individuals has recently been falsely representing themself to be an Iterative Health recruiter and/or hiring manager in email and/or LinkedIn communications with job candidates. We have notified authorities of this conduct. Please note that genuine messages from our team only come from official Iterative Health emails (@iterativescopes.com or @iterative.health) or via one of our recruiters, identified clearly as such, on LinkedIn. If you receive any suspicious messages or would like to verify that your communication with our team is authentic, please do not hesitate to reach out to us at recruiting@iterative.health. Notifying our team will in no way impact any potential hiring decisions made by Iterative Health.